Glioblastoma — Trials

Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

1,750 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 486
Recruiting: 258
Ph III recruiting: 13
Growth YoY: +41%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (282)

clinicaltrialsPublishedShowing 101–102 of 102 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05577091	Tris-CAR-T Cell Therapy for Recurrent Glioblastoma	recruiting	Phase 1	10	Beijing Tiantan HospitalOTHER	1	Apr 12, 2024	clinicaltrials
NCT04443010	Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma(GLIOSUN)	recruiting	Phase 1 / Phase 2	226	Philogen S.p.A.INDUSTRY	1	Oct 10, 2023	clinicaltrials